North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases,

North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)

The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of 22.8% from 2021 to 2028.

The growth of the market is attributed to the rising prevalence of chronic diseases and growing need to reduce the cost of healthcare. However, cyber threat and risk related to data security restrict the market growth.

Chronic diseases, such as heart disease, stroke, diabetes, and obesity, account for most of the healthcare costs of any country. According to a report by the World Health Organization (WHO), 463 million adults in the world had diabetes in 2020, and the number is expected to rise to 629 million by 2045. Moreover, as per the Centers for Disease Control and Prevention (CDC) data published in 2018, 1.4 million Americans are diagnosed with diabetes every year in the US. According to the IDF Diabetes Atlas 2021, published by the International Diabetes Federation, North America reported ~51 million people affected by diabetes in 2021, and the number is expected to reach 63 million by 2045. As per a report by the American College of Cardiology Foundation, coronary heart disease (CHD) was a leading cause of death in the US in 2018, attributable to cardiovascular disease (CVD), followed by stroke (16.8%), high BP (9.4%), heart failure (9.0%), and other CVDs (17.9%). By 2035, ~130 million adults in the US population are projected to suffer from some form of CVDs.

The obesity rates are increasing rapidly in developed and developing economies in North America due to sedentary and unhealthy lifestyles. As per data published by the Organization for Economic Co-operation (OECD) in 2017, ~19.5% of the adult population was obese in OECD area. This rate is less than 6% in Korea and Japan, and more than 30% in Hungary, New Zealand, Mexico, and the US. Obesity levels are anticipated to reach ~47%, ~39%, and ~35% in the US, Mexico, and England, respectively, by 2030.

To enhance chronic disease management and offer various treatment options to patients, digital therapeutics help deliver evidence-based therapeutic solutions. It enable patients to better control their care and provides potential solutions for chronic diseases management, such as diabetes. Hence, the rise in the prevalence of chronic diseases is driving the digital therapeutics market growth.

North America Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)

North America Digital Therapeutics Market Segmentation

By Application

Diabetes Cardiovascular Diseases Central Nervous System (CNS) Disease Respiratory Smoking Cessation Musculoskeletal Diseases Others By End User

Patients Providers Payers Employers By Country

•US•Canada•Mexico Company Profiles

•Propeller Health (Res Med)•Canary Health•Noom, Inc•2Morrow, Inc.•Teladoc Health, Inc.•Welldoc, Inc.•Fitbit, Inc.•Omada Health, Inc.•MANGO HEALTH•Pear Therapeutics, Inc.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America digital therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.